Renishaw Stock: Record Q4 Revenue Delivers 14% Full Year Growth
Renishaw has reported record fourth quarter revenue and 14% full year growth, beating its own guidance on stronger semiconductor and electronics demand.
You are viewing a historical snapshot of United Kingdom (London Stock Exchange). These figures are a preview to show what TradeTidings covers. Live, continuously updated United Kingdom sentiment and stock impact is a Pro feature.
Get live United Kingdom data with ProOver the last 90 days, Technology Hardware shows 6 positive, 0 neutral and 1 negative news signals across its constituents. The auto-generated sector insight (top drivers with direction + rationale) appears here once the analysis worker has processed enough items.
Informational only, not investment advice. Sentiment reflects news exposure, not a buy/sell recommendation or price forecast. Do your own research and consult a licensed professional.
How news sentiment on the Technology Hardware sector has built up over time. Each bar sums the direction of every story TradeTidings published in the period, weighted by how influential we rated it, not just a plain count, so a single high-influence negative story can outweigh several small positive ones. Hover a bar for its exact figures, or click one to filter the stories below to that period. Our own original analysis, not a copied index or a price chart, and not a prediction.
The most recent stories affecting Technology Hardware, across all of our coverage.
Renishaw has reported record fourth quarter revenue and 14% full year growth, beating its own guidance on stronger semiconductor and electronics demand.
Renishaw faces demand headwinds affecting guidance.
Halma has bought pathology automation specialist Dreampath Diagnostics, adding tissue sample management technology to its medical division as part of its ongoing bolt-on acquisition strategy.
Bank of America has turned more positive on Halma, upgrading the safety and environmental technology group and pointing to a brighter growth outlook ahead.
Halma plc has acquired Dreampath Diagnostics, a routine bolt-on deal that fits its long-running strategy of buying small, specialist safety and health technology businesses.
Halma has bought Dreampath Diagnostics, adding a specialist diagnostics business to its healthcare portfolio as it continues its long-running bolt-on acquisition strategy.
Halma has confirmed another acquisition through a stock exchange announcement, continuing its long running strategy of buying small safety and environmental technology firms.